147 related articles for article (PubMed ID: 38127062)
1. Tumor-induced osteomalacia.
Fukumoto S
Panminerva Med; 2024 Jun; 66(2):188-197. PubMed ID: 38127062
[TBL] [Abstract][Full Text] [Related]
2. [Osteomalacia due to phosphate deficiency caused by a tumor. Focus on FGF23 in physiology and clinic].
Westerberg PA; Linde T; Ljunggren O
Lakartidningen; 2012 Aug 8-21; 109(32-33):1414-6. PubMed ID: 22953430
[No Abstract] [Full Text] [Related]
3. A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.
Arai R; Onodera T; Terkawi MA; Mitsuhashi T; Kondo E; Iwasaki N
BMC Musculoskelet Disord; 2017 Feb; 18(1):79. PubMed ID: 28193220
[TBL] [Abstract][Full Text] [Related]
4. Tumor-induced osteomalacia: experience from a South American academic center.
González G; Baudrand R; Sepúlveda MF; Vucetich N; Guarda FJ; Villanueva P; Contreras O; Villa A; Salech F; Toro L; Michea L; Florenzano P
Osteoporos Int; 2017 Jul; 28(7):2187-2193. PubMed ID: 28341900
[TBL] [Abstract][Full Text] [Related]
5. Tumor-Induced Osteomalacia and the Importance of Plasma Fibroblast Growth Factor 23 as an Indicator: Diagnostic Delay Leads to a Suicide Attempt.
Seemann L; Padala SA; Mohammed A; Belayneh N
J Investig Med High Impact Case Rep; 2019; 7():2324709619895162. PubMed ID: 31850815
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in fibroblast growth factor 23-related hypophosphatemic disorders.
Takashi Y; Kawanami D; Fukumoto S
Curr Opin Endocrinol Diabetes Obes; 2024 Aug; 31(4):170-175. PubMed ID: 38687287
[TBL] [Abstract][Full Text] [Related]
7. Osteomalacia induced by a phosphaturic mesenchymal tumor secreting fibroblast growth factor 23.
Nagae K; Uchi H; Ito T; Moroi Y; Oda Y; Furue M
Eur J Dermatol; 2015 Apr; 25(2):199-200. PubMed ID: 25788099
[No Abstract] [Full Text] [Related]
8. Tumor-induced Osteomalacia Caused by a Parotid Tumor.
Takashi Y; Kinoshita Y; Ito N; Taguchi M; Takahashi M; Egami N; Tajima S; Nangaku M; Fukumoto S
Intern Med; 2017; 56(5):535-539. PubMed ID: 28250301
[TBL] [Abstract][Full Text] [Related]
9. Acquired Forms of Fibroblast Growth Factor 23-Related Hypophosphatemic Osteomalacia.
Ito N; Hidaka N; Kato H
Endocrinol Metab (Seoul); 2024 Apr; 39(2):255-261. PubMed ID: 38467164
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics of Malignant Phosphaturic Mesenchymal Tumor Causing Tumor-Induced Osteomalacia.
Abate V; Vergatti A; De Filippo G; Damiano V; Menale C; D'Elia L; Rendina D
J Clin Endocrinol Metab; 2024 Feb; 109(3):e1006-e1011. PubMed ID: 38006315
[TBL] [Abstract][Full Text] [Related]
11. Challenges in the management of tumor-induced osteomalacia (TIO).
Brandi ML; Clunie GPR; Houillier P; Jan de Beur SM; Minisola S; Oheim R; Seefried L
Bone; 2021 Nov; 152():116064. PubMed ID: 34147708
[TBL] [Abstract][Full Text] [Related]
12. Tumour-induced osteomalacia: the long road to diagnosis and recovery.
Vollmer S; Olsson K
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38697682
[TBL] [Abstract][Full Text] [Related]
13. Tumor-induced osteomalacia - a mystery illness beyond aches, pains, and depression.
Ni HJ; Clifton-Bligh R; Brzozowska MM
Endocr Regul; 2021 Sep; 55(3):163-168. PubMed ID: 34523297
[No Abstract] [Full Text] [Related]
14. Sinonasal hemangiopericytoma caused hypophosphatemic osteomalacia: A case report.
Li J; Huang Y; Yang F; Zhang Q; Chen D; Wang Q
Medicine (Baltimore); 2018 Dec; 97(52):e13849. PubMed ID: 30593185
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced hypophosphatemic osteomalacia diagnosed by the combinatory procedures of magnetic resonance imaging and venous sampling for FGF23.
Nasu T; Kurisu S; Matsuno S; Tatsumi K; Kakimoto T; Kobayashi M; Nakano Y; Wakasaki H; Furuta H; Nishi M; Sasaki H; Suzuki H; Ito N; Fukumoto S; Nanjo K
Intern Med; 2008; 47(10):957-61. PubMed ID: 18480582
[TBL] [Abstract][Full Text] [Related]
16. Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.
Hu FK; Yuan F; Jiang CY; Lv DW; Mao BB; Zhang Q; Yuan ZQ; Wang Y
Chin J Cancer; 2011 Nov; 30(11):794-804. PubMed ID: 22035861
[TBL] [Abstract][Full Text] [Related]
17. [Tumor-induced hypophosphatemic osteomalacia].
Ito N; Fukukmoto S
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):731-6. PubMed ID: 17506312
[No Abstract] [Full Text] [Related]
18. Tumor induced osteomalacia.
Filipová L; Lazúrová I
Vnitr Lek; 2021; 67(E-8):19-22. PubMed ID: 35459330
[TBL] [Abstract][Full Text] [Related]
19. Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.
Mori Y; Ogasawara T; Motoi T; Shimizu Y; Chikazu D; Tamura K; Fukumoto S; Takato T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Mar; 109(3):e57-63. PubMed ID: 20219587
[TBL] [Abstract][Full Text] [Related]
20. Tumor-induced osteomalacia: a case report.
Aligail K; Dave JA; Ross IL
J Med Case Rep; 2022 Jan; 16(1):22. PubMed ID: 35016725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
